Clinical Trials

ScreenPoint’s AI breast cancer screening tool hits detection success in new study

ScreenPoint Medical has demonstrated the value of its AI-powered Transpara: Breast AI screening tool in a new study. The Netherlands-based company’s Mammography Screening with Artificial...

Wandercraft launches clinical trial of Personal Exoskeleton technology

Wandercraft kicked off a landmark clinical trial for its Personal Exoskeleton technology. The device aims to offer upright motion and walking independence for individuals...

Newronika wins FDA IDE clearance for Adaptive DBS System clinical trial

Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device Exemption (IDE) from the...

Movano Health kicks off cuffless blood pressure device study

Movano Health announced that it commenced a blood pressure clinical trial with its new cuffless wrist wearable. Pleasanton, California-based Movano designed its updated device to...

Median Technologies’ eyonis™ screening meets primary endpoint in RELIVE clinical trial

Median Technologies announced that eyonis™ LCS, its wholly owned proprietary AI/ML-based CADe/CADx Software as a Medical Device (SaMD) for lung cancer screening, met the...

Aethlon Medical treats first subject with Hemopurifier device in Australia

US-based Aethlon Medical has treated the first subject with its Hemopurifier investigational device in its Australian cancer trial. Designed for subjects with solid tumours, the...

BrightHeart’s AI demonstrates promise in congenital heart defect detection

BrightHeart’s AI-based software for prenatal congenital heart defect (CHD) screening has demonstrated promise in two new studies. The French company’s AI software received 510(k) clearance...

Swiss startup Risklick launches AI-based software for medical device clinical trials

Risklick, a spin-off from the University of Bern, has launched its latest product, Protocol AI, for medical devices. Protocol AI is the first software of...

Pulse Biosciences touts positive results from PFA early feasibility study

Pulse Biosciences has reported positive results from a first-in-human feasibility study evaluating its nanosecond pulsed field ablation (nsPFA) technology for the treatment of atrial...
1...91011...58Page 10 of 58

Latest articles